305 results on '"Chirmule, Narendra"'
Search Results
2. Orphan drug development: Challenges, regulation, and success stories
3. Current status and future prospective of breast cancer immunotherapy
4. Applications of Organoids in Advancing Drug Discovery and Development
5. A survey of awareness of diagnosis and treatment of rare diseases among healthcare professionals and researchers in India
6. Biopharmaceutical Industry Capability Building in India: Report from a Symposium
7. An Overview of Current Accomplishments and Gaps of COVID-19 Vaccine Platforms and Considerations for Next Generation Vaccines
8. Biopharmaceutical Development in India: Recommendations on Collaboration and Innovation to Enable Affordable Healthcare
9. Mentoring during the COVID-19 pandemic: a perspective from graduate students in biomedical science studies in India
10. Assessment of Functional Characterization and Comparability of Biotherapeutics: a Review
11. Predicting the severity of disease progression in COVID-19 at the individual and population level: A mathematical model
12. An explainable machine learning data analytics method using TIGIT-linked genes for identifying biomarker signatures to clinical outcomes.
13. Understanding Quality Paradigm Shifts in the Evolving Pharmaceutical Landscape: Perspectives from the USP Quality Advisory Group
14. Platform-Specific Risk Assessment of SARS-CoV-2 Vaccines Using FMEA: Amid the rush for a SARS-CoV-2 vaccine to deal with the COVID-19 pandemic, a robust risk assessment must be conducted and mitigation strategies applied
15. Reimagining Affordable Biosimilars: Advances in preclinical development play a crucial role in reducing cost for developing biosimilars
16. Understanding preclinical and clinical immunogenicity risks in novel biotherapeutics development
17. Stable Transgene Expression in Rod Photoreceptors after Recombinant Adeno-Associated Virus-Mediated Gene Transfer to Monkey Retina
18. A four-part guide to lung immunology: Invasion, inflammation, immunity, and intervention
19. Overcoming challenges to CAR-T cell therapies in India
20. Immune Hyperactivation of HIV-1-Infected T Cells Mediated by Tat and the CD28 Pathway
21. Teaching vaccine development in schools: Learnings from a survey and curriculum design for a course
22. Immune Suppression During Preclinical Drug Development Mitigates Immunogenicity-Mediated Impact on Therapeutic Exposure
23. Digital health initiatives can take better cognizance of marginalized communities in India
24. On the Manufacturers of Biosimilars in Asia
25. Advanced strategies in glycosylation prediction and control during biopharmaceutical development: Avenues toward industry 4.0
26. The Happy Hopping of Transposons: The Origins of V(D)J Recombination in Adaptive Immunity
27. CAR-T cell therapy in India requires a paradigm shift in training, education and health care processes
28. Assessment of Functional Characterization and Comparability of Biotherapeutics: a Review
29. Biopharmaceutical Industry Capability Building in India: Report from a Symposium
30. On the Manufacturers of Biosimilars in Asia.
31. Human Immunodeficiency Virus Type 1 Envelope Glycoprotein gp120 Produces Immune Defects in CD4 + T Lymphocytes by Inhibiting Interleukin 2 mRNA
32. Primary Combined Immunodeficiency Resulting from Defective Transcription of Multiple T-Cell Lymphokine Genes
33. In vitro Synthesis of Human Immunodeficiency Virus-Specific Antibodies in Peripheral Blood Lymphocytes of Infants
34. Superantigen Staphylococcal Enterotoxin B-Induced T-Helper Cell Activation is Independent of CD4 Molecules and Phosphatidylinositol Hydrolysis
35. Stratification of Antibody-Positive Subjects by Antibody Level Reveals an Impact of Immunogenicity on Pharmacokinetics
36. Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
37. Assessment of immunogenicity of romiplostim in clinical studies with ITP subjects
38. Comparing Exponentially Weighted Moving Average and Run Rules in Process Control of Semiquantitative Immunogenicity Immunoassays
39. Failure Mode and Effects Analysis (FMEA) for Immunogenicity of Therapeutic Proteins
40. Recommendations for Enhancing Quality and Capability of Indian Biopharmaceutical Industry: Summary of a Workshop
41. Strategic characterization of anti-drug antibody responses for the assessment of clinical relevance and impact
42. A Step-wise Approach for Transfer of Immunogenicity Assays during Clinical Drug Development
43. Predicting the severity of disease progression in COVID-19 at the individual and population level: A mathematical model
44. Immunogenicity testing strategy and bioanalytical assays for antibody–drug conjugates
45. Detection of anti-ESA antibodies in human samples from PRCA and non-PRCA patients: an immunoassay platform comparison
46. Modulation of granulocyte colony stimulating factor conformation and receptor binding by methionine oxidation
47. Impact of matrix-associated soluble factors on the specificity of the immunogenicity assessment
48. Assessing specificity for immunogenicity assays
49. The Optimization and Validation of the Glycoprotein ELISA Assay for Quantitative Varicella-Zoster Virus (VZV) Antibody Detection
50. Macrophage ablation attenuates adenoviral vector–induced pancreatitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.